Imatinib use in the management of a patient with Doege–Potter syndrome

SUMMARY: Doege–Potter syndromeis a paraneoplastic syndrome characterized by nonislet cell tumor hypoglycemia due to a solitary fibrous tumor, which produces insulin-like growth factor II. In this report, we present the case of a 67-year-old male with recurrent and refractory hypoglycemia due to DPS...

Descripción completa

Detalles Bibliográficos
Autores principales: Paz-Ibarra, Jose, Lu-Antara, Jose, Uscamayta, Brenda-Erendida, Martinez-Auris, Jhancy, Valencia-Rivera, Miriam, Sáenz-Bustamante, Sofía, Delgado-Rojas, Marialejandra, Salcedo-Vasquez, Julia, Concepción-Zavaleta, Marcio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Novel Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241232/
https://www.ncbi.nlm.nih.gov/pubmed/37931416
http://dx.doi.org/10.1530/EDM-22-0360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241232/
https://www.ncbi.nlm.nih.gov/pubmed/37931416
http://dx.doi.org/10.1530/EDM-22-0360

Ejemplares similares